NewGenIvf Group Past Earnings Performance
Past criteria checks 1/6
NewGenIvf Group's earnings have been declining at an average annual rate of -71.6%, while the Healthcare industry saw earnings growing at 5.2% annually. Revenues have been declining at an average rate of 13.6% per year. NewGenIvf Group's return on equity is 26.7%, and it has net margins of 2.5%.
Key information
-71.6%
Earnings growth rate
-73.4%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | -13.6% |
| Return on equity | 26.7% |
| Net Margin | 2.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How NewGenIvf Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 5 | 0 | 2 | 0 |
| 31 Dec 22 | 6 | 0 | 1 | 0 |
| 31 Dec 21 | 4 | 0 | 1 | 0 |
Quality Earnings: NIVF has a high level of non-cash earnings.
Growing Profit Margin: NIVF's current net profit margins (2.5%) are lower than last year (7.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if NIVF's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: NIVF's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: NIVF had negative earnings growth (-71.6%) over the past year, making it difficult to compare to the Healthcare industry average (7.8%).
Return on Equity
High ROE: NIVF's Return on Equity (26.7%) is considered high.